Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
- PublisherSAGE PUBLICATIONS LTD
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2300
- Publication Time15
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2008
- Publisher URL
- Website URL
- Plagiarism
- Publication Time15
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 6% |
4-6 | 49% |
7-9 | 31% |
>9 | 14% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Therapeutic Advances in Neurological Disorders been publishing? 
The Therapeutic Advances in Neurological Disorders has been publishing since 2008 till date.
How frequently is the Therapeutic Advances in Neurological Disorders published? 
Therapeutic Advances in Neurological Disorders is published Continuous publication.
Who is the publisher of Therapeutic Advances in Neurological Disorders? 
The publisher of Therapeutic Advances in Neurological Disorders is SAGE PUBLICATIONS LTD.
How can I view the journal metrics of Therapeutic Advances in Neurological Disorders on editage? 
For the Therapeutic Advances in Neurological Disorders metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Therapeutic Advances in Neurological Disorders? 
The eISSN number is 1756-2864 and pISSN number is 1756-2856 for Therapeutic Advances in Neurological Disorders.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Cladribine, Multiple sclerosis, Parkinson's disease, Ischemic stroke, Alemtuzumab, Patient satisfaction, Breast milk, Cerebrospinal fluid, Placebo, Progressive multifocal leukoencephalopathy, Magnetic resonance imaging, Acute ischemic stroke, Confidence interval, Safety profile, Quality of life, Peginterferon beta-1a, Myopathy, Dimethyl fumarate, Natalizumab, Rituximab.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.